| abstract |
Equation (I): (R 1, R 2, R 3 and R 4 are as described herein) discloses a pharmaceutical formulation comprising a compound or a pharmaceutically acceptable salt of. Also, a method for treating pancreatic adenocarcinoma, which comprises the step of administering a compound of formula (I) or a pharmaceutically acceptable salt thereof, and one or both of FoxA1 and FoxO6 in a pancreatic adenocarcinoma tumor sample from a mammal. Provided are methods for detecting changes in expression levels (mammals have been administered a compound of formula (I) or a pharmaceutically acceptable salt thereof). [Selection diagram] FIG. 49A |